Objectives: The purpose of this study was to develop and validate a clinical prediction rule to screen patients at risk of vancomycin-resistant enterococci (VRE) carriage at intensive care unit (ICU) admission in a hospital setting with low VRE prevalence.
Introduction
Vancomycin-resistant enterococci (VRE) are a major nosocomial pathogen worldwide despite laborious and costly infection control efforts. 1, 2 Early prevention and control strategies for hospital acquisition of VRE have mainly targeted crosstransmission among hospitalized patients and healthcare workers in endemic areas. 3, 4 Subsequent studies demonstrated the importance of the influx of VRE into healthcare institutions, and indicated it as an additional target to contain VRE endemicity with the aim of achieving substantial cost savings as well as preservation of the benefits of active surveillance. 5 -11 Since the guideline published in 2003 that recommended an active surveillance programme for VRE control, 4 clinical prediction rules to identify the VRE reservoir at hospital admission have been developed in primary studies. 7, 8, 12 However, the clinical variables are not completely identical and also need to be further validated in different healthcare settings with low VRE prevalence.
The purpose of this study was to construct a mathematical model to identify VRE carriage at intensive care unit (ICU) admission, and to develop a clinical prediction rule based on the stratified risk-scoring system in a hospital setting with low VRE prevalence.
Materials and methods

Hospital setting
This study was undertaken in both the medical and surgical ICUs of a 950 bed, university-affiliated hospital, located in Seoul, Republic of Korea. The hospital infection control practices for VRE carriers require strict contact isolation precautions, including use of private rooms or cohorting in ICUs, hand washing, gloving and gowning, and environmental cleansing. 3, 4 Since September 2006, the hospital has run a programme of active surveillance of rectal cultures on a weekly basis for VRE acquisition in all patients who stay in the ICUs for more than 24 h. The programme was extended from April 2008 to screen patients at ICU admission for VRE carriage.
Study design
To generate and validate a clinical prediction rule for identifying patients with VRE carriage at the time of ICU admission, this study was retrospectively conducted using data from the active surveillance programme for VRE carriage and clinical cultures. In the derivation cohort from April 2008 to September 2010, a case-control study was performed to determine the risk factors associated with VRE carriage at ICU admission, and a clinical prediction rule was generated using a risk-scoring system. A case was defined as an adult patient (≥18 years) who had a VRE isolate from screening rectal culture at ICU admission. A control was defined as an adult patient who did not have a VRE isolate from either the screening culture at ICU admission or the following weekly surveillance culture.
Data collection
Clinical data from a computerized hospital database were available for each patient, and included age, gender, comorbid conditions based on the discharge diagnosis, 13 clinical severity at ICU admission, 14 history of hospitalization or operation during the past 12 months, receipt of procedures and medications, length of hospital stay before ICU admission, prior ICU admission, antibiotic use for more than 3 days and microbial culture in the last 3 months. They also included medical histories in the other hospitals, based on the patients' medical records.
The study was approved by the hospital institutional review boards. All clinical data analysed were obtained in a subset of ICU patients through a routine hospital surveillance programme for the infection control. Thus, informed consent was waived.
Microbiological methods
Isolation and detection of VRE from rectal swab samples was carried out as described previously. 15, 16 The time interval between performing surveillance cultures and physicians' receipt of culture results was 3-5 days during the study period.
Statistical analyses
To construct a predictive model and to obtain a validation of a model's performance, the existing active surveillance data for VRE carriage were split into derivation and validation datasets. In the derivation cohort from October 2010 to March 2011, every patient with VRE carriage was included as a case in this analysis. A control was randomly selected from the pool of eligible control subjects who had no VRE isolation, based on an allocation ratio of 2 : 1 for a control group versus a case group. The 'Selected Cases' option from the Data menu in the SPSS software was used to obtain random samples. We confirmed that controls were evenly distributed through the year. The validation cohort included all patients from whom VRE surveillance cultures were taken from October 2010 to March 2011.
Risk factors for VRE carriage were compared between case and control groups using the x 2 test or Fisher's exact test. Multivariate logistic regression analysis was performed using forward stepwise variable selection based on the Wald statistic. Variables with P, 0.05 were included in the final logistic regression model. Random bootstrap sampling with 1000 replications was performed to validate covariate selection in the multivariate analysis. 17 After confirming stability of the b-coefficients to the bootstrap sample, point values were assigned to each independent risk factor based on the b-coefficients to calculate and simplify the risk scoring for its practical use. 18 Variables with regression coefficients closer to 1 were assigned 1 point, those with a value closer to 2 received 2 points and those with a value closer to 3 received 3 points. Receiver operating characteristic (ROC) curve analysis using the risk score was carried out to generate a risk index to identify patients who had an increased probability of VRE carriage. The discriminative ability of the models with regard to the derivation and validation populations was assessed by means of AUC (area under the ROC curve), which is equivalent to a concordance index (C-index). 19 Hosmer -Lemeshow goodness-of-fit tests were used to evaluate calibration of models.
To compare the performance of the published clinical prediction rules or variables with ours, we formulated and applied the prediction rules or variables from the previous four studies to our derivation population. 7, 8, 12, 20 The ability to predict VRE carriage at ICU admission was evaluated by the AUC. SPSS 15.0 (SPSS Inc., Chicago, IL, USA) and SAS 9.2 (SAS Institute, Cary, NC, USA) were used to perform multivariate logistic regression analysis and to simulate the validation of estimates, respectively.
Results
VRE prevalence in ICUs
During the study period, from April 2008 to March 2011, a total of 5937 patients were admitted to ICUs. Of them, rectal cultures for VRE were obtained from 4445 patients (derivation cohort 3384; validation cohort 1061) at the time of ICU admission except those who were discharged from the ICUs within 24 h. The prevalence of VRE colonization at ICU admission in the derivation and the validation cohorts was 3.3% (115/3384) and 3.6% (38/1061), respectively. All of the enterococcal isolates were identified as Enterococcus faecium strains. For the same period, the isolation rate of VRE from both the weekly active surveillance cultures and clinical cultures was 11.4% (643/5618 patients), based on an isolate per patient, and the rectal acquisition rate was 4.2/1000 patient-days.
Construction of the prediction model for VRE carriage at ICU admission
In the derivation cohort, 345 patients, comprising 115 cases with VRE carriage and 230 controls without VRE carriage, were enrolled into the study (Figure 1 ). For a patient with multiple ICU admissions, in the case group, only the first admission was selected as a case. On the other hand, all overlapping patients before VRE acquisition were included in the control group. However, as a result of random selections from the control group, duplicated cases in the control group were only two control patients.
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The demographic and clinical characteristics of the case and control groups in the derivation cohort are presented in Table 1 . In multivariable regression analysis, four variables were independently associated with VRE carriage at the time of ICU admission ( Table 2) . The model showed outstanding discriminatory power and fit, with an AUC value of 0.90 and Hosmer -Lemeshow test yielding a P value of 0.647.
In the bootstrap analysis, the mean and standard errors of b-coefficients did not differ from those of the risk prediction model, except that of recent vancomycin use (Table 3) . However, when we re-evaluated the model alternatively, with 3 points assigned to the parameter of vancomycin use, the C-index of the model was 0.904 and the P value of the Hosmer -Lemeshow x 2 statistic was 0.222.
Development of a clinical prediction rule for VRE carriage at ICU admission
Based on the point values assigned to the identified risk factors, we applied the prediction rule to our derivation population. The risk scores ranged from 0 to 7 points for each patient enrolled.
In the derivation population, the proportion according to the stratified risk index and the probability of VRE carriage at ICU admission are shown in Table 4 . When a cut-off value of ≥3 points was used for the prediction rule, the sensitivity, specificity, positive predictive value and negative predictive value of this prediction rule was 87.8%, 84.4%, 73.9% and 93.7%, respectively. The comparative performance of the prediction rules or variables from the previous four studies and this study is shown in Table 5 . The predictability of our study was the best, based on AUC value.
Validation of the prediction model for VRE carriage at ICU admission
The validation cohort consisted of 1061 patients who were screened for rectal VRE carriage at ICU admission from October 2010 to March 2011. The demographic factors in the validation cohort were not different from those in the derivation group: male gender [validation, n¼ 656 (61.8%), versus derivation, n¼ 217 (62.9%); P¼ 0.722] and age (62.95+15.71 versus 60.69+16.41 years; P ¼0.269). The admission route to ICUs was from a general ward for 359 patients (33.8%), from other hospitals for 21 (2.0%) and from home for 681 (64.2%).
When subjected to the risk-scoring system, scores for all patients fell in the range 0 -6 points. In the validation cohort, the proportion by the stratified risk index and the probability of VRE carriage at ICU admission was summarized in Table 4 . This prediction risk model showed excellent accuracy (C-index 0.83; 95% CI 0.77-0.90) and excellent calibration (HosmerLemeshow x 2 statistic, P,0.001). As predicted, limiting screening cultures to those with high risk would have identified 211 VRE carriers. It attained a sensitivity of 84.2%, a specificity of 82.5%, a positive predictive value of 15.2% and a negative predictive value of 99.3%.
Discussion
This retrospective study, using existing data from an active surveillance culture programme for VRE, developed a clinical prediction rule to identify high-risk patients for VRE carriage at ICU admission. This easily self-reportable scoring system, if applied during initial evaluation at ICU entry, might be valuable to contain VRE transmission by culture screening and the Several studies have reported a prevalence of VRE carriage on ICU admission ranging between 2.5% and 25%. 12,20 -24 In this study, the overall prevalence of VRE carriage at ICU admission was 3.4% (153/4445). However, in a recent Korean nationwide study, the isolation rates of vancomycin-resistant E. faecium in hospitals were 25.9% -41.7%. 25 This might strengthen the need for the strategies to control VRE influx into a healthcare institution.
This study identified four risk factors for VRE carriage at ICU admission: ICU readmission during hospitalization, chronic obstructive pulmonary disease (COPD), recent antibiotic use and recent vancomycin use. COPD is not a commonly identified risk factor for VRE carriage. However, it was reported previously that patients colonized or infected with VRE were more likely to have COPD, and had statistically longer stays in hospital or ICU. 26 We also speculated that VRE acquisition in our COPD patients is linked to longer stays in hospital or the ICU (data not shown).
In this study, we also assessed the performance of the prediction rules or risk factors for VRE carriage at hospital or ICU admission of the previous four studies. 7, 8, 12, 20 The study by Tacconelli et al. 7 retrospectively validated the prediction rule through the internal validation cohort. While their performance showed a sensitivity of 44% -100% and specificity of 28% -98.0% in primary studies, the AUC values of the previous rules applied to our population were lower than that of this study. These findings might indicate that clinical prediction rules should be validated in the other healthcare settings before their use in clinical practice.
There are limitations in our study. First, this study was performed retrospectively in a single centre. This prediction rule needs to be prospectively validated in other healthcare settings before its use in clinical practice. Second, the low positive predictive value of 15.2% in the validation cohort limits its usefulness in routine clinical practice. However, the low positive predictive value is a consequence of the low VRE prevalence in our setting. 7, 12 Additionally, our clinical prediction rule would be expected to reduce the screening volume markedly (by 80.1%), limiting the cultures to patients with high risk. Third, random selection of 230 controls from the 3269 VRE non-carriers by the SPSS software might cause selection bias. However, in the bootstrap analysis, the mean and standard errors of the b-coefficients were not significantly different from those of the risk prediction model. Corticosteroid use was defined as the receipt of ≥ 20 mg/day prednisone equivalent for more than 5 days within the previous 3 months.
f Repeated admissions to ICU during the same hospitalization period. Prediction of VRE carriage at admission
In conclusion, our clinical prediction model may be useful for the better containment of endemic VRE via the early identification and the pre-emptive isolation of VRE carriage at ICU admission. Once externally validated in other clinical settings, this risk-scoring system, as a simple screening tool, could be applicable for impeding the influx of VRE into a healthcare institution.
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